维普中文期刊产品整合服务
313篇 您的检索式:作者名="BLANN A"
    题名 作者 年代 出处 被引量
1Von Willebrand Factor,Soluble P-selectin,and Target Organ Damage in Hypertension:A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)显示文摘Spencer C G Gurney D Blann A D 2002Hypertension2002,40,:1
2Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dys-function in systemic lupus erythematosus 显示文摘Constans J Dupuy R Blann A D 2003J Rheumatol2003,30,9:1
3显示文摘Lip GYH Blann A 1997Cardiovasc Res1997,34,2:1
4Platelet indexes in relation to target organ damage in highrisk hypertensive patients:a substudy of the AngloScandinavian Cardiac Outcomes Trial(ASCOT)显示文摘NADAR S K BLANN A D KAMATH S 2004J Am Coll Cardiol2004,44,:1
5Ethylene tetramerization: A new route to produce l-oetene in exceptionally high seleetivities显示文摘Bollmann A Blann K Dixon J T 2004J Am Chem Sue2004,126,14:1
6The use of bis(diphenylphosphino) amines with N-aryl functionalities in selective ethylene tri- and tetramerisation显示文摘Killian E Blann K Bollmann A 2007Journal of Molecular Catalysis A: Chemical2007,270,1:1
7Von willebrand factor: a marker of endothelial dysfunction in vascular disorders? 显示文摘Lip GYH Blann A 1997Cardiovasc Res1997,34,2:1
8Astudy of platelet activation in atrial fibrillation and the effects of antithrombotic therapy显示文摘KAMATH S BLANN A D CHIN B S 2002Eur Heart J2002,23,:1
9Soluble CD40 ligand and atrial fibrillation:relationship to platelet activation,and endothelial damage/dysfunction显示文摘Blann AD Choudhury A Freestone B 2008Int J Cardiol2008,127,1:1
10Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease显示文摘Blann AD Davis A Miller JP 1997Am J Hematol1997,55,1:1
11Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation 显示文摘LI-SAW-HEE F L BLANN A D LIP G Y 2000Stroke2000,31,:1
12Highly selective chromium-based ethylene trimerisation catalystswith bulky diphosphinoamine ligands 显示文摘BLANN K BOLLMANN A DIXON J T 2005Chem Commun2005,,5:1
13Von willebrand factor, endothelial cell damage and atherosclerosis显示文摘Blann A D McCollum CN 1994Eur Vasc Surg1994,8,:1
14Ethylene tetramerisation: subtle effects exhibited by N-substituted diphosphinoamine ligands 显示文摘BLANN K BOLLMANN A DEBOD H 2007Journal of Catalysis2007,249,2:1
15A contemporary view- point on 'aspirin resistance' 显示文摘Kuzniatsova N Shantsila E Blann A 2012Ann Med2012,44,8:1
16Eth- ylene trimerisation and tetramerisation catalysts with polar- substituted diphosphinoamine ligands 显示文摘OVERETT M J BLANN K BOLLMANN A 2005Chem Commun2005,7,5:1
17von Willebrand factor: a marker of endothelial dysfunction in vascular disorders显示文摘Lip GYH Blann A 1997Cardiovasc Res1997,34,2:1
18Vascular endothelial growth factor and its receptor, Fit-1, in the plasma of patients with coronary or peripheral atherosclerosis, or type Ⅱ diabetes显示文摘BLANN A D BELGORE F M MCCOLLUM C N 2002Clin Sci2002,102,:1
19Elevated platelet micro- particle levels in nonvalvular atrial fibrillation: Relationship to P- selectin and antithrombotic therapy 显示文摘Choudhury A Chung I Blann AD 2007Chest2007,131,3:1
20Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals显示文摘BLANN A D MC COLLUM C N LIP G Y 2002Blood Coagul Fibrinolysis2002,13,6:1
返回顶部 每页显示:
共16页 首页 上一页 第1页 下一页 末页 /16 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费